InsidersTradesSigma
인벤티지랩 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 인벤티지랩 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 인벤티지랩 has recorded 8 reports. Market capitalisation: €373.8bn. The latest transaction was disclosed on 5 June 2026 (Sale). Among the most active insiders: 송순호. The full history is free.
8
Insider Decl.
n/a
Thresholds
€97,188
4 ops.
Buy Volume
€22m
4 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 June 2026
Declarations8 total
8 of 8 declarations
About 인벤티지랩
InvenTige Lab is a company in the health and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance healthcare.